AstraZeneca Appoints Dr. Mike Poole to Lead New ‘Virtual’ Neuroscience Innovative Medicines Unit

Tuesday, 7 February 2012

AstraZeneca today announced the appointment of Dr. Mike Poole to lead its newly created virtual Neuroscience Innovative Medicines Unit (iMed) with the responsibility for a portfolio of large and small molecule projects.  

Read article

Download our brochure

Download your comprehensive guide to partnering with us.

Meet us at an event

Calendar iconView our full event calendar to see events we are attending.

View calendar

Bookmark & Share